After an acquisition of Bayer Animal Health in 2020, Elanco has made progress in paying down debt. Robust pipeline with six potential blockbuster products to be launched in 2024 and 2025. Improving ...

Düsseldorf (Reuters) - Der Leverkusener Bayer-Konzern hat sich von einem Teil seiner Aktien des US-Tiergesundheitsunternehmen Elanco Animal Health getrennt. 54,5 Millionen Elanco-Aktien seien am ...

Across the recent three months, 4 analysts have shared their insights on Elanco Animal Health (NYSE:ELAN), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll ...

4 analysts have shared their evaluations of Elanco Animal Health (NYSE:ELAN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed ...

Aug 2 (Reuters) - A former unit of German life-sciences giant Bayer convinced a federal jury in California on Thursday that it did not block a pet care startup from competing in the retail market for ...

In a recent SEC filing, it was revealed that Jeffrey N Simmons, President at Elanco Animal Health (NYSE:ELAN), made a noteworthy insider purchase on December 15,. What Happened: Simmons made a ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

In this settled action, In the Matter of Elanco Animal Health, Inc., Elanco, a manufacturer and seller of animal health products, such as flea and tick medications, was charged with “failure to ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches, despite a 20.5% stock decline since August 2024. The stock drop is mainly due to safety risks with the ...